NEVVI Medicare utilization intelligence
or

← back

Provider profile

VANNESS, ERIN MD

Dermatology · NPI 1912976135 · STATE COLLEGE, PA

1
Groups
18
Codes · 2024
1,795
Disclosed services

VANNESS, ERIN is a Dermatology in STATE COLLEGE, PA, a member of 1 medical group, who billed 18 distinct codes to Medicare Part B in 2024.

Groups: UPMC ALTOONA REGIONAL HEALTH SERVICES, INC. (ALTOONA, PA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

1,795
disclosed services
18
codes billed to Medicare Part B
Prior year · CY2023 679 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
11102 Biopsy of related skin growth, first growth
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
11103 Biopsy of related skin growth, each additional growth
17000 Destruction of precancer skin growth, 1 growth
17110 Destruction of skin growth, 1-14 growths
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
11900 Injection into skin growth, 1-7 growths
69100 Biopsy of ear
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
11104 Punch biopsy, first skin growth
11604 Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.